The Real Reason Shadow AI Is Spreading
May 12, 2026
When lab tools fail to support interpretation and decision-making, scientists find alternatives
3 min read
False
Advertisement
2026
This Week’s Biopharma News: Amgen Deepens US Manufacturing Push
May 12, 2026
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
6 min read
Industrializing Organoids to Bridge the Predictability Gap
May 11, 2026
As regulators move away from animal testing, scalable organoid platforms and standardized iPSC inputs could help close the gap between preclinical models and human biology
4 min read
This Week’s CGT News: CAR-T Breaks New Ground in Alzheimer’s
May 11, 2026
First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD
6 min read
Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
May 7, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar
May 5, 2026
Plus: NICE backs rozanolixizumab for uncontrolled gMG, Genexine reports SOX2 degrader data, and BeOne secures option on Huahui trispecific antibody
4 min read
What Sponsors Get Wrong When Initiating an Oncology Study
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
This Week’s CGT News: CRISPR Hits Phase 3 Milestone
May 4, 2026
Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal
6 min read
